Trump’s drug price plan faces resistance from physicians, hospitals & big pharma
President Donald Trump’s proposal to lower Medicare drug costs, which was first announced Oct. 25, is drawing resistance from various segments of the healthcare industry — including physicians, pharma companies and hospitals, according to Politico.
